tiprankstipranks
IRESS Limited (AU:IRE)
ASX:IRE

IRESS Limited (IRE) AI Stock Analysis

41 Followers

Top Page

AU:IRE

IRESS Limited

(Sydney:IRE)

Select Model
Select Model
Select Model
Neutral 59 (OpenAI - 5.2)
Rating:59Neutral
Price Target:
AU$8.00
▲(15.27% Upside)
Action:ReiteratedDate:02/26/26
The score is driven primarily by improving financial health (profitability recovery and lower leverage), tempered by weakening revenue and cash-flow momentum. Technicals are the main drag given a clear downtrend versus moving averages and a negative MACD, while valuation provides partial support through a reasonable P/E and moderate dividend yield.
Positive Factors
Deleveraging & equity rebuild
Material deleveraging and stronger equity reduce financial risk and increase optionality. Lower leverage improves capacity to fund R&D, M&A or absorb customer churn, reduces refinancing pressure and supports long-term stability of recurring enterprise contracts.
Negative Factors
Two-year revenue decline
Consecutive annual revenue declines reflect weaker product demand or competitive pressure. Persistent top-line shrinkage reduces operating leverage, limits reinvestment capacity, and risks margin compression if fixed costs or sales investments must be maintained.
Read all positive and negative factors
Positive Factors
Negative Factors
Deleveraging & equity rebuild
Material deleveraging and stronger equity reduce financial risk and increase optionality. Lower leverage improves capacity to fund R&D, M&A or absorb customer churn, reduces refinancing pressure and supports long-term stability of recurring enterprise contracts.
Read all positive factors

IRESS Limited (IRE) vs. iShares MSCI Australia ETF (EWA)

IRESS Limited Business Overview & Revenue Model

Company Description
Iress Limited engages in the designing and developing software and services for the financial services industry in Australia, New Zealand, Asia, the United Kingdom, Europe, South Africa, and North America. It offers client management, business aut...
How the Company Makes Money
IRESS generates revenue primarily through the subscription model for its software products and services. The company charges its clients periodic fees for access to its platforms, which include trading and market data services. Additional revenue ...

IRESS Limited Financial Statement Overview

Summary
Earnings and balance sheet improved meaningfully (return to profitability after 2023 loss; debt reduced and equity rebuilt), but operating momentum is a concern with two straight years of revenue decline and a notable 2025 drop in operating and free cash flow.
Income Statement
63
Positive
Balance Sheet
68
Positive
Cash Flow
54
Neutral
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue556.32M600.83M625.74M615.59M595.95M
Gross Profit148.63M124.22M96.38M167.51M138.59M
EBITDA119.29M154.85M-54.28M119.95M146.39M
Net Income79.26M88.67M-137.48M52.67M73.80M
Balance Sheet
Total Assets670.12M730.22M792.22M1.00B1.03B
Cash, Cash Equivalents and Short-Term Investments55.35M66.19M50.74M63.81M64.87M
Total Debt196.06M234.03M422.96M462.75M389.38M
Total Liabilities247.01M352.12M520.21M566.25M495.71M
Stockholders Equity423.10M378.11M272.01M433.81M536.91M
Cash Flow
Free Cash Flow49.62M82.91M44.24M84.97M77.08M
Operating Cash Flow62.63M104.57M63.66M112.58M101.21M
Investing Cash Flow25.59M129.56M25.79M-31.96M-34.56M
Financing Cash Flow-101.69M-213.43M-108.25M-77.85M-64.39M

IRESS Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price6.94
Price Trends
50DMA
7.42
Negative
100DMA
8.04
Negative
200DMA
8.17
Negative
Market Momentum
MACD
-0.12
Negative
RSI
43.25
Neutral
STOCH
75.71
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:IRE, the sentiment is Negative. The current price of 6.94 is below the 20-day moving average (MA) of 7.10, below the 50-day MA of 7.42, and below the 200-day MA of 8.17, indicating a bearish trend. The MACD of -0.12 indicates Negative momentum. The RSI at 43.25 is Neutral, neither overbought nor oversold. The STOCH value of 75.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:IRE.

IRESS Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
AU$883.15M11.0542.94%10.16%25.67%744.90%
69
Neutral
AU$1.01B12.1917.13%1.85%11.15%105.20%
66
Neutral
AU$1.10B21.1625.65%1.27%5.11%12.91%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
59
Neutral
AU$1.28B19.9119.57%2.47%-4.10%341.80%
55
Neutral
AU$806.91M64.66-1.11%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:IRE
IRESS Limited
6.94
-0.92
-11.73%
AU:HSN
Hansen Technologies Limited
4.98
0.07
1.49%
AU:BVS
Bravura Solutions Limited
1.97
-0.12
-5.83%
AU:OCL
Objective Corporation Limited
11.50
-3.34
-22.52%
AU:FCL
FINEOS Corporation Holdings Plc Shs Chess Depositary Interests Repr 1 Sh
2.34
0.34
17.00%

IRESS Limited Corporate Events

Iress lodges updated ASX corporate governance statement for 2025
Feb 24, 2026
Iress Limited has lodged its latest corporate governance statement with the ASX for the financial year ended 31 December 2025, confirming that the document is available on its website and has been approved by the board as at 25 February 2026. The ...
IRESS Sets Interim Dividend of 13 Cents per Share
Feb 24, 2026
IRESS Limited has declared an interim dividend of AUD 0.13 per ordinary fully paid share for the six-month period ended 31 December 2025, with an ex-dividend date of 10 March 2026 and a record date of 11 March 2026. The payment is scheduled for 8 ...
Iress lifts pre-tax profit despite revenue slide and negative NTA
Feb 24, 2026
Iress Limited reported a 7.4% decline in revenue from ordinary activities to $556.3 million for the year ended 31 December 2025, while profit before income tax rose 21.5% to $109.2 million. Net profit attributable to shareholders fell 10.6% to $79...
Iress Sets Date for 2025 Full-Year Results and Investor Call
Jan 27, 2026
Iress Limited, the financial technology provider to wealth management, trading, market data and broader financial services sectors, will release its 2025 full-year financial results for the period ending 31 December 2025 on 25 February 2026. The c...
Norges Bank Ceases to Be Substantial Shareholder in IRESS
Jan 18, 2026
Norges Bank has notified IRESS Limited that it has ceased to be a substantial shareholder in the company as of 15 January 2026, following the return of collateral shares amounting to 1,356,943 common shares. The change reduces Norges Bank’s ...
Norges Bank Ceases to Be Substantial Shareholder in IRESS
Jan 8, 2026
Norges Bank has notified IRESS Ltd that it has ceased to be a substantial shareholder in the company as of 7 January 2026, after returning collateral shares and reducing its holding below the substantial holder threshold. The move slightly reshape...
IRESS Reports Lapse of Deferred Share Rights After Conditions Not Met
Jan 6, 2026
IRESS Limited has notified the market of the cessation of 5,879 deferred share rights (IREAC) after these conditional rights lapsed on 28 November 2025 because their specified conditions were not, or could no longer be, satisfied. The relatively s...
Norges Bank Ceases to Be Substantial Shareholder in IRESS
Dec 23, 2025
Norges Bank has notified IRESS Limited that it has ceased to be a substantial shareholder in the company as of 22 December 2025, following the return of collateral shares amounting to 1,277,787 common shares. The move reduces Norges Bank’s v...
IRESS Limited Announces Change in Substantial Holdings
Dec 17, 2025
IRESS Limited has announced a change in substantial holdings, with DNR Capital Pty Ltd ceasing to be a substantial holder in the company. This change may impact voting securities and influence the company’s governance dynamics, potentially a...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 26, 2026